Clinical Trials Directory

Trials / Unknown

UnknownNCT01755585

Irradiation Modulates the Pharmacokinetics of Anticancer Drugs

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Radiation therapy (RT) is used as an effective local treatment modality to inhibit cell proliferation, induce cell death and suppress tumor growth. To improve the treatment outcome, in terms of both locoregional control and survival, the concurrent use of chemotherapy during radiation therapy (CCRT) is now the standard treatment for various malignancies, especially locally advanced cancers. Among the drugs used to enhance RT effect, 5-fluorouracil (5-FU) is one of the most commonly used chemotherapeutic agents of CCRT. In the past, RT was solely used as a local treatment and its effect was estimated by local effect model. However, growing evidence shows that irradiation has direct DNA damage-dependent effects as well as sending signals to neighboring cells. Recently, we reported that abdominal irradiation could significantly modulate the systemic pharmacokinetics of 5-FU at 0.5 Gy, off-target area in clinical practice, and at 2 Gy, the daily treatment dose for target treatment in an experimental rat model. Additionally, the results from a clinical investigation showed that colorectal cancer patients with lower AUC of 5-FU during adjuvant chemotherapy had lower disease-free survival. Taken together, these lines of evidence support the importance and necessity to search for the mediators responsible for the unexpected effect of local RT on systemic pharmacokinetics of chemotherapeutic agents, such as 5-FU. In the present study, the investigators investigated whether the phenomena and mechanism of RT-PK is a fact for different anticancer drugs in human.

Conditions

Timeline

Start date
2011-07-01
Primary completion
2015-12-01
First posted
2012-12-24
Last updated
2014-01-22

Source: ClinicalTrials.gov record NCT01755585. Inclusion in this directory is not an endorsement.

Irradiation Modulates the Pharmacokinetics of Anticancer Drugs (NCT01755585) · Clinical Trials Directory